'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials 19
Clinical Trials by Phase in E7 Countries 21
Clinical Trials in E7 Countries by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Clinical Trials by End Point Status 26
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials 31
Prominent Drugs 33
Clinical Trial Profile Snapshots 34
Appendix 145
Abbreviations 145
Definitions 145
Research Methodology 146
Secondary Research 146
About GlobalData 147
Contact Us 147
Disclaimer 147
Source 148
List of Tables
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Region, 2016* 6
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, North America, Top Countries, 2016* 12
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14
Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 16
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 20
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Phase, 2016* 23
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 24
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 28
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 30
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 32
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 33
List of Figures
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14
Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 15
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 17
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 18
Proportion of Peripheral Neuropathy (Sensory Neuropathy) to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 19
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 21
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 22
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 23
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 24
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 25
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 26
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 27
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 28
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 29
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 31
Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 33
GlobalData Methodology 146